Xiaosheng He
Overview
Explore the profile of Xiaosheng He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
2014
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin Y, Zhang Y, Huang T, Chen J, Li G, Zhang B, et al.
Cancer Res
. 2025 Feb;
PMID: 39992728
Metabolic reprogramming is a hallmark of cancer. Rewiring of amino acid metabolic processes provides the basis for amino acid deprivation therapies. In this study, we found that arginine biosynthesis is...
2.
Chen J, Zhang Y, Chen X, Luo D, Liu D, Yu Z, et al.
Cancer Biother Radiopharm
. 2024 Nov;
40(1):41-53.
PMID: 39585204
Chemotherapy based on oxaliplatin (OXA) is the first-line treatment for advanced colorectal cancer (CRC), and acquired resistance to OXA is the main reason for clinical treatment failure in CRC. To...
3.
He X, Yang F, Liu F, Lin G
IEEE Trans Neural Netw Learn Syst
. 2024 Nov;
PP.
PMID: 39504292
Training a generative model with limited data (e.g., 10) is a very challenging task. Many works propose to fine-tune a pretrained GAN model. However, this can easily result in overfitting....
4.
Chen T, Liu J, Wang C, Wang Z, Zhou J, Lin J, et al.
J Immunother Cancer
. 2024 Aug;
12(8).
PMID: 39142719
Background: Oxylipin metabolism plays an essential role in glioma progression and immune modulation in the tumor microenvironment. Lipid metabolic reprogramming has been linked to macrophage remodeling, while the understanding of...
5.
He D, Wang K, Zhang Y, Jiang X, Chen H, Chen J, et al.
Surg Endosc
. 2024 May;
38(7):3783-3798.
PMID: 38806955
Background: Many studies reported the presence of adenomas with high-grade dysplasia (HGD) at index colonoscopy increased the incidence of advanced neoplasia (AN) and colorectal cancer (CRC) following. However, the conclusion...
6.
Chen J, Li G, He X, Chen X, Chen Z, Liu D, et al.
Gastroenterol Rep (Oxf)
. 2024 May;
12:goae045.
PMID: 38756351
Background: Intestinal fibrosis is a common complication in inflammatory bowel disease (IBD), which still lacks of reliable markers and therapeutic options. Cellular senescence has been considered an important mechanism of...
7.
Chen H, Wang C, Chen Z, Huang T, Lin Y, Chen J, et al.
BMC Cancer
. 2024 Apr;
24(1):433.
PMID: 38589842
Background: Perineural invasion (PNI) is the invasion of nerves by cancer cells and is associated with poor survival in stage II colorectal cancer. However, PNI can be further subdivided according...
8.
Wang K, He H, Lin Y, Zhang Y, Chen J, Hu J, et al.
Int J Colorectal Dis
. 2024 Apr;
39(1):46.
PMID: 38565736
Purpose: Lymph node metastasis (LNM) is a crucial factor that determines the prognosis of T1 colorectal cancer (CRC) patients. We aimed to develop a practical prediction model for LNM in...
9.
Huang Y, Xie Y, Wang P, Chen Y, Qin S, Li F, et al.
Int J Surg
. 2024 Feb;
110(6):3230-3236.
PMID: 38348893
Importance: Patients with pathological complete response (pCR) of rectal cancer following neoadjuvant treatment had better oncological outcomes. However, reliable methods for accurately predicting pCR remain limited. Objective: To evaluate whether...
10.
Knudsen M, Wang K, Wang L, Polychronidis G, Berstad P, Wu K, et al.
EClinicalMedicine
. 2023 Aug;
62:102139.
PMID: 37599907
Background: Effective risk stratification tools for post-polypectomy colorectal cancer (PPCRC) are lacking. We aimed to develop an effective risk stratification tool for the prediction of PPCRC in three large population-based...